Tokyo, Oct. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059473) titled 'Evaluation of the effect of a test product on the skin maintenance of skin elasticity' on Oct. 21.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - KAGOME CO., LTD.

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To assess the effect of a test product on the skin elasticity in men and women aged 35 to 50. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Ingestion of active beverage for 12 weeks Interventions/Control_2 - Ingestion of placebo beverage for 12 weeks

Eligibility: Age-lower limit - 35 years-old = Gender - Male and Female Key inclusion criteria - 1.Healthy Japanese men and women aged 35 to 50 at the time of obtaining consent to participate in the study 2.Individuals who are concerned about skin elasticity Key exclusion criteria - 1. Individuals currently receiving outpatient treatment and using medications 2. Individuals consuming vegetable or vegetable-fruit mix juice three or more times per week 3. Individuals consuming either carrots, pumpkin, spinach, or chrysanthemum greens a total of at least three or more times per week 4. Individuals currently consuming supplements containing carotenoids three or more times per week 5. Individuals currently consuming medications, quasi-drugs, specific health foods, nutritional supplements, functional foods, or so-called health foods that claim skin elasticity improvement, moisturizing effects, or estrogen-like effects at least three times per week 6. Individuals unable to refrain from activities involving excessive UV exposure beyond daily life during the study period. 7. Individuals who have undergone cosmetic procedures on the measurement site 8. Individuals who have received body esthetic treatments on the measurement site within the past month 9. Individuals with chronic skin conditions such as atopic dermatitis 10. Individuals with abnormalities on the measurement site, such as wounds or inflammation 11. Smokers 12. Individuals with a physical constitution that may interfere with blood collection 13. Individuals at risk of showing allergic symptoms upon food 14. Individuals whose average weekly alcohol consumption, converted to pure alcohol, exceeds 40 g/day for men and 20 g/day for women 15. Individuals with asthma 16. Individuals with hay fever 17. Individuals with a BMI below 18.5 or above 25.0 18. Individuals planning overseas travel or extended domestic travel during the study period 19. Individuals working night shifts or rotating shifts 20. Women who are pregnant, breastfeeding, or planning to become pregnant during the study period 21. Individuals participating in another clinical study within the past three months 22. Any other individuals deemed ineligible for this study by the principal investigator Target Size - 80

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 20 Day Date of IRB - 2025 Year 10 Month 20 Day Anticipated trial start date - 2025 Year 12 Month 03 Day Last follow-up date - 2026 Year 03 Month 10 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068022

Disclaimer: Curated by HT Syndication.